2010

Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 2014)

Publisher: Renub Research

Published: September, 2010

Report Details
Our new report Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 2014) examines the commercial prospects for In Vitro Diagnostics (IVD) in the global healthcare market. The report provides market landscape, competitive landscape and market trends information on ten market categories including Molecular Diagnostics, Clinical Chemistry, Hematology, Immunoassay, Point of Care Testing, Microbiology, Histology/Cytology, Flow Cytometry, Blood Screening Typing, and Coagulation. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report reviews the competitive landscape in terms of mergers and acquisitions, licensing, pipeline products and new technology offerings. The report also analyses past present and future forecast of USA, Japan, Europe, India, China and Taiwan IVD market. The report has been researched at source globally and features latest available data covering: Ten IVD sub-segment past, present and future forecast market share Six countries (USA, Japan, Europe, India, China, Taiwan) past, present, future prospects in the IVD market Top eight companies (Sysmex, BioMerieux, OCD (J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens & Roche) IVD market share in 2009 Top ten Merger & Acquisition deals in 2008 and 2009 Licensing by ten IVD players Review of International In Vitro Diagnostics Regulations Key drivers of growth in the global IVD market Key challenges faces by IVD market in the coming years

Research Highlights
Globally, In Vitro Diagnostics market will cross US$ 60 Billion by 2014 Point of Care Testing dominates the In Vitro Diagnostics market with more than 30% market share in 2009

Renub Research

Page 2 of 14

Molecular Diagnostics is the fastest growing segment in the In Vitro Diagnostics market, its market share will reach approximately 18% by 2014 In 2009 Roche, Siemens and Abbott Diagnostics together controls 42% market share in In Vitro Diagnostics, Roche controls the highest market share After Point of Care Testing, Immunoassay is the second largest market with a market of more than US$ 7 Billion in 2009 Europe with more than US$ 10 Billion is the second largest In Vitro Diagnostics Market in 2009 51 Mergers & Acquisitions taken place in 2008 compared to 84 deals in 2007 18 In-Licensing deals were announced in 2008 compared to 27 in 2007 By 2009 there were 12 countries with more than 10 Million people aged 60 or over Third Wave Technologies (TWT) was acquired by Hologic to grow its existing womens health and diagnostics business was the best deal in 2008 In 2009, Beckman Coulter acquired the diagnostic systems part of Olympuss life sciences to broaden its clinical chemistry offering, especially in the ultra-high throughput setting.

Key Players Analyzed This section covers the key facts about the major players in In Vitro Diagnostics market. The key players analyzed in this section are Roche, Sysmex, Biomerieux, OCD(J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens. Data Sources Information and data in this report has been collected from various printable and nonprintable sources like Trade Journals, White papers, Online paid databases, News websites, Government Agencies, Magazines, Newspapers and Trade associations.

Renub Research

Page 3 of 14

Published By

Renub Research
A116B, Sector27 Noida 201301 Phone: +91-120-421-9822, 424-9780 (India) +1-678-302-0700 (US) Email: info@renub.com www.renub.com

Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 2014) Renub Research, 2010 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers

Renub Research

Page 4 of 14

Table of Contents
1. 2. Executive Summary Global In Vitro Diagnostics Market & Future Forecast 2.1 2.2 3. Global In Vitro Diagnostics Market Share & Future Forecast Global IVD Market, Market Share by Company

In Vitro Diagnostics Market Segment Past, Present & Future Forecast 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 Molecular Diagnostics Clinical Chemistry Hematology Immunoassay Point of Care Testing Microbiology Histology/Cytology Flow Cytometry Blood Screening Typing Coagulation

4.

Geographical Segmentation 4.1 4.2 4.3 4.4 4.5 4.6 USA In Vitro Diagnostics Market Japan In Vitro Diagnostics Market Europe In Vitro Diagnostics Market India In Vitro Diagnostics Market China In Vitro Diagnostics Market Taiwan In Vitro Diagnostics Market

5.

Merger & Acquisitions 5.1 5.2 5.3 Mergers & Acquisitions Deals in the IVD Sector, 2009 Number of All Mergers & Acquisitions Deals in the IVD Sector, (2004 - 2008) Top Ten Mergers & Acquisitions Deals in the IVD Sector, 2008

Renub Research

Page 5 of 14

5.4 6.

Value of Disclosed Mergers & Acquisitions Deals in the IVD Sector, (2004 2008)

Licensing By Ten IVD Majors 6.1 6.2 6.3 6.4 Number of In-Licensing Deals Announced, (2004 2008) Number of In-Licensing Deals announced in 2008 by Ten IVD Majors Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies In-Licensing Deals Announced in 2008 by Ten IVD Players

7.

A Review of International IVD Regulations 7.1 7.2 GHTF and AHWP: Elements for a Regulatory System More Emphasis on Environmental Topics Instructions for Use and Other Labeling

7.2.1 7.3

Auditing: A Tool for Improving Processes More Regulated Countries

7.3.1 7.4 8.

Future Leadership and Outlook for the Next 15 Years

Key Drivers of Growth in Global IVD Market 8.1 Aging of the population Population Aged 60 or Over: World and Development Regions, 1950 - 2050 Old-Age Dependency Ratio: Major Areas, 2009 and 2050

8.1.1 8.1.2 8.2 8.3

Personalized Medicine The Future Continued Expansion of Point Of Care Including Self Testing Future of Point of Care Testing The Worried Well Theranostics Companion Diagnostics Hub and Spoke Education

8.3.1 8.3.2 8.3.3 8.3.4 8.4 9.

Pharmacogenetic Testing and New Types of Genetic Disease Screening Tests

Key Challenges In the Global In-Vitro Diagnostics Market 9.1 Regulatory and Reimbursement Issues Coverage Policies

9.1.1 9.2

Manufacturing Obstacles in IVD Product Development Rise in Point of Care (POC) Technologies Avoiding Too Much, Too Soon Closely Considering Materials and Environment

9.2.1 9.2.2 9.2.3

Renub Research

Page 6 of 14

10. 10.1 10.2 10.3 10.4 10.5 10.6 10.7 10.8

Key Players in the Global IVD Market Abbott Laboratories Roche biomerieux Beckman Coulter BD (Becton, Dickinson and Company) Sysmex Siemens Ortho Clinical Diagnostics

Renub Research

Page 7 of 14

List of Figures:
Figure 2-1: Global In Vitro Diagnostic Market (Billion US$), 2007 2009 Figure 2-2: Global Forecast for In Vitro Diagnostics Market (Billion US$), 2010 2014 Figure 2-3: Global Segments of In Vitro Diagnostics Market Share (Percent), 2007 2009 Figure 2-4: Global Forecast for Segments of In Vitro Diagnostics Market Share (Percent), 2010 2014 Figure 2-5: Global In Vitro Diagnostics Market Share of top 8 Companies (Sysmex, BioMerieux, OCD (J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens & Roche) (Percent), 2009 Figure 3-1: Global Molecular Diagnostics Market (Billion US$), 2007 2009 Figure 3-2: Global Forecast for Molecular Diagnostics Market (Billion US$), 2010 2014 Figure 3-3: Global Clinical Chemistry Market (Billion US$), 2006 2009 Figure 3-4: Global Forecast for Clinical Chemistry Market (Billion US$), 2010 2014 Figure 3-5: Global Hematology Market (Billion US$), 2007 2009 Figure 3-6: Global Forecast for Hematology Market (Billion US$), 2010 2014 Figure 3-7: Global Immunoassay Market (Billion US$), 2006 2009 Figure 3-8: Global Forecast for Immunoassay Market (Billion US$), 2010 2014 Figure 3-9: Global Point of Care Testing Market (Billion US$), 2003, 2006 2009 Figure 3-10: Global Forecast for Point of Care Testing Market (Billion US$), 2010 2014 Figure 3-11: Global Microbiology Market (Billion US$), 2006 2009 Figure 3-12: Global Forecast for Microbiology Market (Billion US$), 2010 2014 Figure 3-13: Global Histology/Cytology Market (Billion US$), 2005 2009 Figure 3-14: Global Forecast for Histology/Cytology Market (Billion US$), 2010 2014 Figure 3-15: Global Flow Cytometry Market (Billion US$), 2007 2009 Figure 3-16: Global Forecast for Flow Cytometry Market (Billion US$), 2010 2014 Figure 3-17: Global Blood Screening Typing Market (Billion US$), 2006 2009 Figure 3-18: Global Forecast for Blood Screening Typing Market (Billion US$), 2010 2014 Figure 3-19: Global Coagulation Market (Billion US$), 2006 2009 Figure 3-20: Global Forecast for Coagulation Market (Billion US$), 2010 2014 Figure 4-1: USA In Vitro Diagnostics Market (Billion US$), 2002 2009 Figure 4-2: USA Forecast for In Vitro Diagnostics Market (Billion US$), 2010 2012 Figure 4-3: Japan In Vitro Diagnostics Market (Billion US$), 2002 2009 Figure 4-4: Japan Forecast for In Vitro Diagnostics Market (Billion US$), 2010 2012 Figure 4-5: Europe In Vitro Diagnostics Market (Billion US$), 2002 2009 Figure 4-6: Europe Forecast for In Vitro Diagnostics Market (Billion US$), 2010 2012 Figure 4-7: India In Vitro Diagnostics Market (Million US$), 1996 2009 Figure 4-8: India Forecast for In Vitro Diagnostics Market (Million US$), 2010 2012 Figure 4-9: China In Vitro Diagnostics Market (Million US$), 1995 2009

Renub Research

Page 8 of 14

Figure 4-10: China Forecast for In Vitro Diagnostics Market (Million US$), 2010 2012 Figure 4-11: Taiwan In Vitro Diagnostics Market (Million US$), 2007 2009 Figure 4-12: Taiwan Forecast for In Vitro Diagnostics Market (Million US$), 2010 2012 Figure 5-1: Global Number of All Mergers & Acquisitions Deals in the In Vitro Diagnostics Sector, 2004 2008 Figure 5-2: Global Value of Disclosed Mergers & Acquisitions Deals in the In Vitro Diagnostics Sector (Billion US$) 2004 2008 Figure 6-1: Global Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies 2004 2008 Figure 6-2: Global Number of In-Licensing Deals announced by Ten In Vitro Diagnostics Companies, 2008 Figure 6-3: Global Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies, 2004 2008 Figure 7-1: Global Population Aged 60 or Over: World and Development Regions, 1950, 1975, 2009, 2025 & 2050 Figure 7-2: Global Old-Age Dependency Ratio: Major Areas, 2009 & 2050

Renub Research

Page 9 of 14

List of Table:
Table 5-1: Global Mergers & Acquisitions Deals in the In Vitro Diagnostics Sector, 2009 Table 5-2: Global Top Ten Mergers & Acquisitions Deals in In Vitro Diagnostics Sector (Million US$), 2008 Table 6-1: Global In-Licensing Deals Announced in 2008 by Ten IVD Players Table 7-1: Global Population Aged 60 or Over, 65 or Over and 80 Or Over By Sex (Thousands): World, Major Areas and Regions, 2009 Table 9-1: Abbott Laboratories Key Financials (Million US$) 2007 2009 Table 9-2: Roche Key Financials (Million US$) 2007 2009 Table 9-3: Biomerieux Financials (Million US$) 2007 2009 Table 9-4: Beckman Coulter Financials (Million US$) 2007 2009 Table 9-5: BD (Becton, Dickinson and Company) Financials (Thousand US$) 2008 2009 Table 9-6: Sysmex Financials (Million Yen) 2007 2009 Table 9-7: Siemens Financials (Million Euros) 2008 2009

Renub Research

Page 10 of 14

Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com

Format
Report Title: Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 2014)

Single User (Email from Publisher) US$ 1,200

Hard Copy (Mail Delivery) US$ 1,300

CD Rom (Mail Delivery) US$ 1,300

Global Site License (Multiple User License) US$ 1,700

For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.): http://renub.com/reports/showdetails.aspx?id=31 2) Order by Wire Transfer: http://renub.com/reports/wiretransfer.aspx?id=31&pid=1102 To pay by Wire Transfer, please, fill in your contact details in the form below:

Renub Research

Page 11 of 14

Bank Details
Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi 110001 India

Contact Information
First Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: Last Name:

Renub Research

Page 12 of 14

3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research A -116B Sector -27 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research

Renub Research

Page 13 of 14

About Us
Renub Research
in international is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have more than 7 years of experience especially Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in todays ultra-competitive markets.

Renub Research

Page 14 of 14